Koneksa Announces Study with New York Proton Center to Collect Patient-Generated Health Data During Proton Radiotherapy in Lung Cancer
Digital Health Global
APRIL 25, 2024
This pilot study represents a critical step in leveraging digital health technology to enhance cancer treatment outcomes,” said John Wagner, M.D., Chief Medical Officer, Koneksa. “By Acute toxicities of RT/CRT for lung cancer commonly include fatigue, dermatitis, esophagitis, and respiratory symptoms.
88 
Let's personalize your content